RECIPHARM AB (PUBL) More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 12-31 |
| Director of Finance/CFO | - | 02/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 28/02/21 |
| Director/Board Member | 67 | 31/12/20 | |
Richard Ridinger
CHM | Chairman | 66 | 28/02/21 |
Recipharm AB (publ) is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). The Company's acivities are devided into four business segments: Advanced Delivery Systems, which develops and manufactures inhalation products and devices including integrated drug solutions, medical check valves and injection devices. Steriles, which manufactures sterile products, including the use of lyophilisation and blow-fillseal (BFS) technologies. Solids & Others, which manufactures non-sterile products, including tablets, capsules, semi-solids, liquids and powders but excluding inhalation products and Development & Licensing, which provides pharmaceutical development services, and manages Recipharm's patents, technologies, and drug product rights, as well as the development and manufacturing of drug substance (Active Pharmaceutical Ingredient, API). The Company operates worldwide.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
